trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal
Published 1 year ago • 2.1K plays • Length 51:40Download video MP4
Download video MP3
Similar videos
-
50:09
community context: integrating trop2-targeting adcs into patient-centric breast cancer care
-
57:18
navigating the expanding treatment arsenal for er /her2- breast cancer
-
56:23
are you prepared for the new wave of adcs in nsclc? targeting her2, her3, trop2, and others
-
58:27
addressing key targets in advanced nsclc: her2-, her3-, and trop2-targeted therapies
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
1:25
dato-dxd: a new adc on the block
-
3:48
trop2: a promising breast cancer drug target
-
57:18
translating progress with immunotherapies and targeted agents into improved outcomes in tnbc
-
1:01:42
bmt highlights of astct 2024
-
7:19
breakthrough cancer treatment could be on the horizon with mrna vaccine
-
![[셀트리온 c-files] 항체-약물 접합(adc) 기술이란 무엇일까?](https://i.ytimg.com/vi/Whmvw9hw5Ns/mqdefault.jpg)
5:34
[셀트리온 c-files] 항체-약물 접합(adc) 기술이란 무엇일까?
-
0:54
promising targets in adcs for breast cancer
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
6:51
adcs for her2 and her2-low breast cancer
-
49:56
reshaping the future of lung cancer treatment with trop2-targeting adcs and rational combinations
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
1:26
antibody drug conjugate sacituzumab govitecan shows efficacy in tnbc
-
26:57
ep 4: oncology morning commute: targeting her2, her3, and trop2 in nsclc
-
0:59
sequencing her2-targeted therapies in breast cancer
-
3:01
resistance to adcs in breast cancer and novel combination strategies
-
35:25
antibody drug conjugates and recent applications in breast cancer treatment
-
0:55
utilizing actionable classifications in tnbc